Abstract
As the world endures the coronavirus disease 2019 (COVID-19) pandemic, the conditions of 35 million vulnerable individuals struggling with substance use disorders (SUDs) worldwide have not received sufficient attention for their special health and medical needs. Many of these individuals are complicated by underlying health conditions, such as cardiovascular and lung diseases and undermined immune systems. During the pandemic, access to the healthcare systems and support groups is greatly diminished. Current research on COVID-19 has not addressed the unique challenges facing individuals with SUDs, including the heightened vulnerability and susceptibility to the disease. In this systematic review, we will discuss the pathogenesis and pathology of COVID-19, and highlight potential risk factors and complications to these individuals. We will also provide insights and considerations for COVID-19 treatment and prevention in patients with SUDs.
Funder
National Institute on Drug Abuse
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference245 articles.
1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
2. A Novel Coronavirus from Patients with Pneumonia in China, 2019
3. WHO Coronavirus Disease (COVID-19) Dashboardhttps://covid19.who.int/?gclid=CjwKCAjw_-D3BRBIEiwAjVMy7IzWSCeKBbqAB9-TFuuZjmGDDMEdt6ZvGZjjKeqBgN3kIA6kRl9XEhoCG9kQAvD_BwE
4. Coronavirus Resource Centerhttps://coronavirus.jhu.edu/
5. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19–11 March 2020https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献